Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.14
-0.03 (-0.58%)
At close: Nov 22, 2024, 4:00 PM
5.16
+0.02 (0.39%)
After-hours: Nov 22, 2024, 5:47 PM EST
Annexon Market Cap
Annexon has a market cap or net worth of $547.89 million as of November 22, 2024. Its market cap has increased by 346.47% in one year.
Market Cap
547.89M
Enterprise Value
237.38M
1-Year Change
346.47%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $639.51M to $547.89M, a decrease of -14.33%. That is a compound annual growth rate of -3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 550.02M | 54.65% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | 955.09M | 49.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 566.78M |
| Corvus Pharmaceuticals | 566.09M |
| Surmodics | 561.15M |
| Third Harmonic Bio | 560.98M |
| Ironwood Pharmaceuticals | 554.50M |
| GRAIL | 551.72M |
| Omeros | 549.44M |
| Astria Therapeutics | 546.28M |